---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-036032"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2026-08-04T21:25:40+00:00"
generated_at: "2026-08-04T21:26:12.653317+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Processa shareholders approve 200,000-share increase to 2019 Omnibus Incentive Plan at annual meeting

## Summary
- All six director nominees elected with votes for ranging from 696,796 to 710,505; broker non-votes 825,288.
- Amendment to 2019 Omnibus Incentive Plan to increase shares by 200,000 approved: 579,877 for, 152,958 against, 2,700 abstain.
- Ratification of Cherry Bekaert as auditor: 1,541,664 for, 12,770 against, 6,389 abstain.
- Advisory say-on-pay approved: 640,726 for, 89,886 against, 4,923 abstain.

## SEC filing metadata
- accession: 0001493152-26-036032
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2026-08-04T21:25:40+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/0001493152-26-036032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-036032
- JSON: https://secwatch.observer/filing/0001493152-26-036032.json
- Plain text: https://secwatch.observer/filing/0001493152-26-036032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.